Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Daniel E.H. Afar"'
Autor:
Daniel E.H. Afar, Shmuel Yaccoby, Bart Barlogie, John D. Shaughnessy, Fenghuang Zhan, Audie G. Rice, Debra Chao, Bishwa Ganguly, Balaji Balasa, Rui Yun, Amberly M. Moreno-Bost, JuMei Shi, Tarun K. Garg, Mary K. Stone, Xin Li, Anne M. van Abbema, Myles Dillon, Susann M. Szmania, Frits van Rhee
Supplementary Data from Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ceb3c738108976650d682599b1dbd3
https://doi.org/10.1158/1535-7163.22486031
https://doi.org/10.1158/1535-7163.22486031
Autor:
Philippe Moreau, Jesús F. San-Miguel, Anil Singhal, Bruno Paiva, Anita Reddy, James P. Sheridan, Scott Gulbranson, Shekman Wong, Katja Weisel, Xavier Leleu, Andrzej J. Jakubowiak, Joaquín Martínez-López, Andreas Guenther, Marc S. Raab, Jesús G. Berdeja, María-Victoria Mateos, Daniel E.H. Afar, Rajneesh Nath, Ravi Vij
Overall summary of treatment-emergent adverse events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::072e401dc2fdc93db09c050b8ac6354a
https://doi.org/10.1158/1078-0432.22471553.v1
https://doi.org/10.1158/1078-0432.22471553.v1
Autor:
Philippe Moreau, Jesús F. San-Miguel, Anil Singhal, Bruno Paiva, Anita Reddy, James P. Sheridan, Scott Gulbranson, Shekman Wong, Katja Weisel, Xavier Leleu, Andrzej J. Jakubowiak, Joaquín Martínez-López, Andreas Guenther, Marc S. Raab, Jesús G. Berdeja, María-Victoria Mateos, Daniel E.H. Afar, Rajneesh Nath, Ravi Vij
Purpose:ABBV-838 is an antibody–drug conjugate targeting a unique epitope of CD2 subset 1, a cell-surface glycoprotein expressed on multiple myeloma cells. This phase I/Ib first-in-human, dose-escalation study (trial registration ID: NCT02462525) e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b92335383f066e12e00748e447cf92c
https://doi.org/10.1158/1078-0432.c.6527927.v1
https://doi.org/10.1158/1078-0432.c.6527927.v1
Autor:
Philippe Moreau, Jesús F. San-Miguel, Anil Singhal, Bruno Paiva, Anita Reddy, James P. Sheridan, Scott Gulbranson, Shekman Wong, Katja Weisel, Xavier Leleu, Andrzej J. Jakubowiak, Joaquín Martínez-López, Andreas Guenther, Marc S. Raab, Jesús G. Berdeja, María-Victoria Mateos, Daniel E.H. Afar, Rajneesh Nath, Ravi Vij
Study design schematic. N, number of patients in each dose group; PK/PD, pharmacokinetics/pharmacodynamics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b8ad54bf2863964b9eb23f6cb05576d
https://doi.org/10.1158/1078-0432.22471556
https://doi.org/10.1158/1078-0432.22471556
Autor:
Daniel E.H. Afar, Shmuel Yaccoby, Bart Barlogie, John D. Shaughnessy, Fenghuang Zhan, Audie G. Rice, Debra Chao, Bishwa Ganguly, Balaji Balasa, Rui Yun, Amberly M. Moreno-Bost, JuMei Shi, Tarun K. Garg, Mary K. Stone, Xin Li, Anne M. van Abbema, Myles Dillon, Susann M. Szmania, Frits van Rhee
Monoclonal antibody (mAb) therapy for multiple myeloma, a malignancy of plasma cells, has not been clinically efficacious in part due to a lack of appropriate targets. We recently reported that the cell surface glycoprotein CS1 (CD2 subset 1, CRACC,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ef3d3e9283c21d752107367ae7e8ce8
https://doi.org/10.1158/1535-7163.c.6532202
https://doi.org/10.1158/1535-7163.c.6532202
Publikováno v:
Combinatorial chemistryhigh throughput screening. 5(1)
Using a combinatorial peptide library that is based on the one-bead one-peptide approach we identified 14 peptide substrates for the c-ABL protein tyrosine kinase, which define three distinct consensus sequence groups. This is distinct from many seri
Publikováno v:
Letters in Peptide Science; Nov1996, Vol. 3 Issue 5, p309-316, 8p
Publikováno v:
Journal of Cellular Biochemistry; Jan1995 Supplement 19A, Vol. 59, p1-86, 86p
The 11 th meeting in'Modern Trends in Human Leukemia'took place from June 19 to 21, 1994 in Wilsede in the middle of the Liineburger Heide, South of Hamburg. Interwoven with the Leukemia program was the Nato-sponsored Symposium of the ASI-Series'Gene